{"gene":"CTSA","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2013,"finding":"Mutations in the CTSA gene, encoding protective protein/cathepsin A (PPCA), cause secondary deficiency of both β-galactosidase (GLB1) and neuraminidase 1 (NEU1), establishing PPCA as required for the functional stability/protection of both lysosomal enzymes in the galactosialidosis disease mechanism.","method":"CTSA mutation analysis in galactosialidosis patients combined with computational functional prediction; review of established biochemical consequences of CTSA loss","journal":"Orphanet journal of rare diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated across multiple independent patient cohorts and multiple labs; biochemical consequence of CTSA loss on GLB1 and NEU1 is an established mechanistic finding confirmed in multiple studies","pmids":["23915561"],"is_preprint":false},{"year":2019,"finding":"CTSA protective protein/cathepsin A is required for functional activity of lysosomal β-galactosidase and neuraminidase, confirmed by demonstrating impaired β-galactosidase and neuraminidase function in cultured skin fibroblasts from a patient with a compound heterozygous CTSA mutation.","method":"Enzymatic assay of β-galactosidase and neuraminidase activity in cultured skin fibroblasts from patient with CTSA mutations; Sanger sequencing","journal":"Human genome variation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct enzymatic assay in patient fibroblasts with identified CTSA mutations, single lab, consistent with replicated findings across the field","pmids":["31044084"],"is_preprint":false},{"year":2025,"finding":"A novel homozygous missense CTSA variant (p.Gln436Arg) impairs the dimerization process of protective protein/cathepsin A (PPCA), potentially disrupting proper protein maturation or function, leading to significantly reduced PPCA activity.","method":"In vitro functional analysis of CTSA variant; enzymatic activity assay; exome sequencing","journal":"Annals of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vitro functional analysis supports dimerization impairment, single lab, single study","pmids":["40165614"],"is_preprint":false},{"year":2020,"finding":"Cathepsin A (CTSA) degrades lysosomal-associated membrane protein 2a (LAMP2a), a rate-limiting factor of chaperone-mediated autophagy; leptin downregulates CTSA expression, leading to LAMP2a accumulation and upregulation of chaperone-mediated autophagy. CTSA localizes to lysosomes where it performs this degradation function.","method":"Western blot, real-time PCR, immunocytochemistry, lysosome isolation in canine inflammatory mammary adenocarcinoma (CHMp) cells treated with leptin; LAMP2a multimerization assessed via lysosomal fractionation","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — lysosome isolation with functional consequence (LAMP2a degradation), multiple orthogonal methods (WB, ICC, fractionation), single lab","pmids":["33255835"],"is_preprint":false},{"year":1991,"finding":"The human protective protein (PPGB/CTSA) gene is localized to the long arm of chromosome 20.","method":"Fluorescence in situ hybridization (FISH) with single- and double-color techniques using 1.8-kb PPGB cDNA and 12-kb genomic fragment probes on normal lymphocyte prometaphase chromosome spreads; confirmed by hybridization with whole chromosome DNA libraries","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct FISH mapping with two independent probes, confirmed by chromosome library hybridization","pmids":["2071143"],"is_preprint":false},{"year":1994,"finding":"The mouse homologue of PPGB (Ppgb/Ctsa) maps to the conserved region on distal mouse chromosome 2 and is not subject to parental imprinting; both maternal and paternal alleles are expressed in mouse brain and kidney.","method":"Linkage analysis using mouse reciprocal translocations; RT-PCR analysis of Ppgb expression in mice with maternal duplication/paternal deficiency and reciprocal for distal Chr 2","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RT-PCR allelic expression analysis with genetic crosses, single lab, two complementary approaches","pmids":["7959780"],"is_preprint":false}],"current_model":"CTSA encodes protective protein/cathepsin A (PPCA), a lysosomal serine protease that directly protects β-galactosidase (GLB1) and neuraminidase 1 (NEU1) from premature degradation, maintaining their activity; PPCA also degrades LAMP2a within lysosomes to regulate chaperone-mediated autophagy, and its function requires proper homodimerization for maturation and activity."},"narrative":{"mechanistic_narrative":"CTSA encodes protective protein/cathepsin A (PPCA), a lysosomal protein required for the functional stability of the lysosomal enzymes β-galactosidase (GLB1) and neuraminidase 1 (NEU1); loss of CTSA function causes secondary deficiency of both enzymes and underlies the lysosomal storage disorder galactosialidosis [PMID:23915561]. This protective role has been confirmed directly in patient cells, where compound heterozygous CTSA mutations impair both β-galactosidase and neuraminidase activity [PMID:31044084]. PPCA activity depends on proper protein maturation: a homozygous missense variant that impairs PPCA dimerization markedly reduces enzymatic activity, indicating that homodimerization is required for function [PMID:40165614]. Beyond its protective function, PPCA acts as a lysosomal protease that degrades LAMP2a, a rate-limiting component of chaperone-mediated autophagy, thereby coupling CTSA expression levels to autophagic flux [PMID:33255835]. The CTSA gene maps to human chromosome 20q and its mouse homologue is biallelically expressed without parental imprinting [PMID:2071143, PMID:7959780].","teleology":[{"year":1991,"claim":"Before functional characterization, the chromosomal position of the protective protein gene was unknown; mapping it established the human locus and a foundation for disease-gene linkage.","evidence":"FISH mapping with cDNA and genomic probes on lymphocyte chromosome spreads","pmids":["2071143"],"confidence":"High","gaps":["Does not address the protein's biochemical function","No mutation or phenotype data"]},{"year":1994,"claim":"It was unclear whether the gene was subject to genomic imprinting; allelic expression analysis showed biallelic expression, ruling out imprinting as a regulatory layer.","evidence":"Linkage analysis and RT-PCR of allelic expression in mouse crosses with maternal/paternal chromosome imbalances","pmids":["7959780"],"confidence":"Medium","gaps":["Mouse data; human imprinting status not directly tested in this finding","No mechanistic link to enzyme protection"]},{"year":2013,"claim":"The disease mechanism of galactosialidosis was resolved by establishing that CTSA loss causes secondary deficiency of both GLB1 and NEU1, defining PPCA as a protector of these enzymes' stability.","evidence":"CTSA mutation analysis in galactosialidosis patients with computational prediction and review of biochemical consequences","pmids":["23915561"],"confidence":"High","gaps":["Molecular basis of how PPCA physically protects GLB1/NEU1 not detailed here","Does not address other PPCA substrates or roles"]},{"year":2019,"claim":"The requirement of PPCA for partner enzyme activity was confirmed directly in patient cells rather than inferred, by measuring impaired β-galactosidase and neuraminidase activity in fibroblasts carrying CTSA mutations.","evidence":"Enzymatic assays in cultured patient skin fibroblasts with Sanger-confirmed CTSA mutations","pmids":["31044084"],"confidence":"Medium","gaps":["Single patient/single lab","Does not resolve which residues mediate enzyme protection"]},{"year":2020,"claim":"A protective function did not explain whether PPCA itself acts proteolytically; CTSA was shown to degrade LAMP2a in lysosomes, linking it to regulation of chaperone-mediated autophagy.","evidence":"Western blot, RT-PCR, immunocytochemistry and lysosomal fractionation in leptin-treated canine mammary adenocarcinoma cells","pmids":["33255835"],"confidence":"Medium","gaps":["Demonstrated in a canine cancer cell line","Direct proteolysis of LAMP2a by PPCA not reconstituted biochemically","Generality across human tissues unestablished"]},{"year":2025,"claim":"How specific missense mutations abolish PPCA function was addressed by showing a p.Gln436Arg variant impairs dimerization, establishing homodimerization as a requirement for maturation and activity.","evidence":"In vitro functional analysis and enzymatic assay of an exome-identified CTSA variant","pmids":["40165614"],"confidence":"Medium","gaps":["Single variant, single study","Structural basis of dimerization defect not resolved","Link between dimerization and enzyme-protection function not directly tested"]},{"year":null,"claim":"The molecular interface by which PPCA physically associates with and protects GLB1 and NEU1, and the structural relationship between its protective and proteolytic functions, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the PPCA-GLB1-NEU1 complex in the corpus","Direct substrate repertoire of PPCA protease activity incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[3]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[3]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0]}],"complexes":[],"partners":["GLB1","NEU1","LAMP2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P10619","full_name":"Lysosomal protective protein","aliases":["Carboxypeptidase C","Carboxypeptidase L","Cathepsin A","Protective protein cathepsin A","PPCA","Protective protein for beta-galactosidase"],"length_aa":480,"mass_kda":54.5,"function":"Protective protein appears to be essential for both the activity of beta-galactosidase and neuraminidase, it associates with these enzymes and exerts a protective function necessary for their stability and activity. This protein is also a carboxypeptidase and can deamidate tachykinins","subcellular_location":"Lysosome","url":"https://www.uniprot.org/uniprotkb/P10619/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CTSA","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CTSA","total_profiled":1310},"omim":[{"mim_id":"621394","title":"BRAIN SMALL VESSEL DISEASE 6 WITH LEUKOENCEPHALOPATHY; BSVD6","url":"https://www.omim.org/entry/621394"},{"mim_id":"619723","title":"SERINE CARBOXYPEPTIDASE 1; SCPEP1","url":"https://www.omim.org/entry/619723"},{"mim_id":"613111","title":"CATHEPSIN A; CTSA","url":"https://www.omim.org/entry/613111"},{"mim_id":"611458","title":"GALACTOSIDASE, BETA-1; GLB1","url":"https://www.omim.org/entry/611458"},{"mim_id":"608272","title":"NEURAMINIDASE 1; NEU1","url":"https://www.omim.org/entry/608272"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Vesicles","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"adrenal gland","ntpm":312.4}],"url":"https://www.proteinatlas.org/search/CTSA"},"hgnc":{"alias_symbol":[],"prev_symbol":["GSL","PPGB"]},"alphafold":{"accession":"P10619","domains":[{"cath_id":"3.40.50.1820","chopping":"32-211_375-477","consensus_level":"high","plddt":98.3371,"start":32,"end":477},{"cath_id":"3.40.50.1820","chopping":"213-330","consensus_level":"medium","plddt":92.289,"start":213,"end":330}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P10619","model_url":"https://alphafold.ebi.ac.uk/files/AF-P10619-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P10619-F1-predicted_aligned_error_v6.png","plddt_mean":94.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CTSA","jax_strain_url":"https://www.jax.org/strain/search?query=CTSA"},"sequence":{"accession":"P10619","fasta_url":"https://rest.uniprot.org/uniprotkb/P10619.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P10619/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P10619"}},"corpus_meta":[{"pmid":"2071143","id":"PMC_2071143","title":"The gene encoding human protective protein (PPGB) is on chromosome 20.","date":"1991","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/2071143","citation_count":85,"is_preprint":false},{"pmid":"10028254","id":"PMC_10028254","title":"Proposal to transfer Halococcus turkmenicus, Halobacterium trapanicum JCM 9743 and strain GSL-11 to Haloterrigena turkmenica gen. nov., comb. nov.","date":"1999","source":"International journal of systematic bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/10028254","citation_count":69,"is_preprint":false},{"pmid":"11201788","id":"PMC_11201788","title":"Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion.","date":"2000","source":"Glycoconjugate journal","url":"https://pubmed.ncbi.nlm.nih.gov/11201788","citation_count":50,"is_preprint":false},{"pmid":"23915561","id":"PMC_23915561","title":"Galactosialidosis: review and analysis of CTSA gene mutations.","date":"2013","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23915561","citation_count":47,"is_preprint":false},{"pmid":"25164783","id":"PMC_25164783","title":"Human genetic disorders involving glycosylphosphatidylinositol (GPI) anchors and glycosphingolipids (GSL).","date":"2014","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/25164783","citation_count":45,"is_preprint":false},{"pmid":"30013364","id":"PMC_30013364","title":"miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA.","date":"2018","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30013364","citation_count":45,"is_preprint":false},{"pmid":"22477389","id":"PMC_22477389","title":"Reducing progoitrin and enriching glucoraphanin in Brassica napus seeds through silencing of the GSL-ALK gene family.","date":"2012","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22477389","citation_count":39,"is_preprint":false},{"pmid":"26657321","id":"PMC_26657321","title":"Biofortification of oilseed Brassica juncea with the anti-cancer compound glucoraphanin by suppressing GSL-ALK gene family.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26657321","citation_count":39,"is_preprint":false},{"pmid":"23456206","id":"PMC_23456206","title":"GSL-enriched membrane microdomains in innate immune responses.","date":"2013","source":"Archivum immunologiae et therapiae experimentalis","url":"https://pubmed.ncbi.nlm.nih.gov/23456206","citation_count":32,"is_preprint":false},{"pmid":"26420879","id":"PMC_26420879","title":"Quantitative GSL-glycome analysis of human whole serum based on an EGCase digestion and glycoblotting method.","date":"2015","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/26420879","citation_count":32,"is_preprint":false},{"pmid":"30459784","id":"PMC_30459784","title":"The Role of Promoter-Associated Histone Acetylation of Haem Oxygenase-1 (HO-1) and Giberellic Acid-Stimulated Like-1 (GSL-1) Genes in Heat-Induced Lateral Root Primordium Inhibition in Maize.","date":"2018","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/30459784","citation_count":23,"is_preprint":false},{"pmid":"21886858","id":"PMC_21886858","title":"Complete genome sequence of the extremely halophilic Halanaerobium praevalens type strain (GSL).","date":"2011","source":"Standards in genomic sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21886858","citation_count":19,"is_preprint":false},{"pmid":"2146256","id":"PMC_2146256","title":"The expression of IV6 beta[Gal beta 1-4(Fuc alpha 1-3)GlcNAc]-Gb5Cer in mouse kidney is controlled by the Gsl-5 gene through regulation of UDP-GlcNAc:Gb5Cer beta 1-6N-acetylglucosaminyltransferase activity.","date":"1990","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2146256","citation_count":18,"is_preprint":false},{"pmid":"31044084","id":"PMC_31044084","title":"A new heterozygous compound mutation in the CTSA gene in galactosialidosis.","date":"2019","source":"Human genome variation","url":"https://pubmed.ncbi.nlm.nih.gov/31044084","citation_count":15,"is_preprint":false},{"pmid":"38360082","id":"PMC_38360082","title":"GSL-DTI: Graph structure learning network for Drug-Target interaction prediction.","date":"2024","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/38360082","citation_count":12,"is_preprint":false},{"pmid":"33255835","id":"PMC_33255835","title":"Leptin Modulates the Metastasis of Canine Inflammatory Mammary Adenocarcinoma Cells Through Downregulation of Lysosomal Protective Protein Cathepsin A (CTSA).","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33255835","citation_count":10,"is_preprint":false},{"pmid":"36255681","id":"PMC_36255681","title":"Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).","date":"2023","source":"Advances in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/36255681","citation_count":9,"is_preprint":false},{"pmid":"7959780","id":"PMC_7959780","title":"Protective protein for beta-galactosidase, Ppgb, maps to the distal imprinting region of mouse chromosome 2 but is not imprinted.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7959780","citation_count":7,"is_preprint":false},{"pmid":"38795858","id":"PMC_38795858","title":"Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes.","date":"2024","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/38795858","citation_count":5,"is_preprint":false},{"pmid":"28555253","id":"PMC_28555253","title":"A Turkish case of galactosialidosis with a new homozygous mutation in CTSA gene.","date":"2017","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/28555253","citation_count":5,"is_preprint":false},{"pmid":"23532458","id":"PMC_23532458","title":"Homoeologous GSL-ELONG gene replacement for manipulation of aliphatic glucosinolates in Brassica rapa L. by marker assisted selection.","date":"2013","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/23532458","citation_count":4,"is_preprint":false},{"pmid":"34264097","id":"PMC_34264097","title":"Complete Genome Sequence of an Extremely Halophilic Archaeon from Great Salt Lake, Halobacterium sp. GSL-19.","date":"2021","source":"Microbiology resource announcements","url":"https://pubmed.ncbi.nlm.nih.gov/34264097","citation_count":4,"is_preprint":false},{"pmid":"29876240","id":"PMC_29876240","title":"Galactosialidosis in a Newborn with a Novel Mutation in the CTSA Gene Presenting with Transient Hyperparathyroidism.","date":"2017","source":"Balkan journal of medical genetics : BJMG","url":"https://pubmed.ncbi.nlm.nih.gov/29876240","citation_count":2,"is_preprint":false},{"pmid":"38081446","id":"PMC_38081446","title":"Proteomics analysis of serum and urine identifies VCP and CTSA as potential biomarkers associated with multiple myeloma.","date":"2023","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38081446","citation_count":1,"is_preprint":false},{"pmid":"20163628","id":"PMC_20163628","title":"Exclusion of NEU1 and PPGB from candidate genes for a lysosomal storage disease in Japanese Black cattle.","date":"2009","source":"Animal science journal = Nihon chikusan Gakkaiho","url":"https://pubmed.ncbi.nlm.nih.gov/20163628","citation_count":1,"is_preprint":false},{"pmid":"40165614","id":"PMC_40165614","title":"Novel CTSA Variant Identified in a Thai Family With Late-Infantile Galactosialidosis.","date":"2025","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40165614","citation_count":1,"is_preprint":false},{"pmid":"29333829","id":"PMC_29333829","title":"[Galactosialidosis: a new \"de novo\" mutation in CTSA gene in a patient with late infantile galactosialidosis].","date":"2018","source":"Archivos argentinos de pediatria","url":"https://pubmed.ncbi.nlm.nih.gov/29333829","citation_count":1,"is_preprint":false},{"pmid":"40555816","id":"PMC_40555816","title":"A multifaceted approach of Rhizobium sp. PS1 for biodegradation of azo dye blue GSL and plant growth promotion by alleviating dye induced stress.","date":"2025","source":"World journal of microbiology & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/40555816","citation_count":1,"is_preprint":false},{"pmid":"34007465","id":"PMC_34007465","title":"ReGARDD (Regulatory Guidance for Academic Research of Drugs and Devices): The evolution of a collaborative regional CTSA-funded forum and website for regulatory support.","date":"2021","source":"Journal of clinical and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/34007465","citation_count":1,"is_preprint":false},{"pmid":"38104738","id":"PMC_38104738","title":"Toxic effects and mechanisms of cationic blue SD-GSL on Chlorella vulgaris before and after the biological decolorization process.","date":"2023","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/38104738","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.10.686860","title":"eIF2B Selectively Anchors and Activates Mutant KRAS","date":"2025-11-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.10.686860","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16078,"output_tokens":1471,"usd":0.03515,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8223,"output_tokens":2142,"usd":0.047332,"stage2_stop_reason":"end_turn"},"total_usd":0.082482,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"Mutations in the CTSA gene, encoding protective protein/cathepsin A (PPCA), cause secondary deficiency of both β-galactosidase (GLB1) and neuraminidase 1 (NEU1), establishing PPCA as required for the functional stability/protection of both lysosomal enzymes in the galactosialidosis disease mechanism.\",\n      \"method\": \"CTSA mutation analysis in galactosialidosis patients combined with computational functional prediction; review of established biochemical consequences of CTSA loss\",\n      \"journal\": \"Orphanet journal of rare diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated across multiple independent patient cohorts and multiple labs; biochemical consequence of CTSA loss on GLB1 and NEU1 is an established mechanistic finding confirmed in multiple studies\",\n      \"pmids\": [\"23915561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CTSA protective protein/cathepsin A is required for functional activity of lysosomal β-galactosidase and neuraminidase, confirmed by demonstrating impaired β-galactosidase and neuraminidase function in cultured skin fibroblasts from a patient with a compound heterozygous CTSA mutation.\",\n      \"method\": \"Enzymatic assay of β-galactosidase and neuraminidase activity in cultured skin fibroblasts from patient with CTSA mutations; Sanger sequencing\",\n      \"journal\": \"Human genome variation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct enzymatic assay in patient fibroblasts with identified CTSA mutations, single lab, consistent with replicated findings across the field\",\n      \"pmids\": [\"31044084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A novel homozygous missense CTSA variant (p.Gln436Arg) impairs the dimerization process of protective protein/cathepsin A (PPCA), potentially disrupting proper protein maturation or function, leading to significantly reduced PPCA activity.\",\n      \"method\": \"In vitro functional analysis of CTSA variant; enzymatic activity assay; exome sequencing\",\n      \"journal\": \"Annals of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vitro functional analysis supports dimerization impairment, single lab, single study\",\n      \"pmids\": [\"40165614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cathepsin A (CTSA) degrades lysosomal-associated membrane protein 2a (LAMP2a), a rate-limiting factor of chaperone-mediated autophagy; leptin downregulates CTSA expression, leading to LAMP2a accumulation and upregulation of chaperone-mediated autophagy. CTSA localizes to lysosomes where it performs this degradation function.\",\n      \"method\": \"Western blot, real-time PCR, immunocytochemistry, lysosome isolation in canine inflammatory mammary adenocarcinoma (CHMp) cells treated with leptin; LAMP2a multimerization assessed via lysosomal fractionation\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — lysosome isolation with functional consequence (LAMP2a degradation), multiple orthogonal methods (WB, ICC, fractionation), single lab\",\n      \"pmids\": [\"33255835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"The human protective protein (PPGB/CTSA) gene is localized to the long arm of chromosome 20.\",\n      \"method\": \"Fluorescence in situ hybridization (FISH) with single- and double-color techniques using 1.8-kb PPGB cDNA and 12-kb genomic fragment probes on normal lymphocyte prometaphase chromosome spreads; confirmed by hybridization with whole chromosome DNA libraries\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct FISH mapping with two independent probes, confirmed by chromosome library hybridization\",\n      \"pmids\": [\"2071143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The mouse homologue of PPGB (Ppgb/Ctsa) maps to the conserved region on distal mouse chromosome 2 and is not subject to parental imprinting; both maternal and paternal alleles are expressed in mouse brain and kidney.\",\n      \"method\": \"Linkage analysis using mouse reciprocal translocations; RT-PCR analysis of Ppgb expression in mice with maternal duplication/paternal deficiency and reciprocal for distal Chr 2\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RT-PCR allelic expression analysis with genetic crosses, single lab, two complementary approaches\",\n      \"pmids\": [\"7959780\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CTSA encodes protective protein/cathepsin A (PPCA), a lysosomal serine protease that directly protects β-galactosidase (GLB1) and neuraminidase 1 (NEU1) from premature degradation, maintaining their activity; PPCA also degrades LAMP2a within lysosomes to regulate chaperone-mediated autophagy, and its function requires proper homodimerization for maturation and activity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CTSA encodes protective protein/cathepsin A (PPCA), a lysosomal protein required for the functional stability of the lysosomal enzymes β-galactosidase (GLB1) and neuraminidase 1 (NEU1); loss of CTSA function causes secondary deficiency of both enzymes and underlies the lysosomal storage disorder galactosialidosis [#0]. This protective role has been confirmed directly in patient cells, where compound heterozygous CTSA mutations impair both β-galactosidase and neuraminidase activity [#1]. PPCA activity depends on proper protein maturation: a homozygous missense variant that impairs PPCA dimerization markedly reduces enzymatic activity, indicating that homodimerization is required for function [#2]. Beyond its protective function, PPCA acts as a lysosomal protease that degrades LAMP2a, a rate-limiting component of chaperone-mediated autophagy, thereby coupling CTSA expression levels to autophagic flux [#3]. The CTSA gene maps to human chromosome 20q and its mouse homologue is biallelically expressed without parental imprinting [#4, #5].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Before functional characterization, the chromosomal position of the protective protein gene was unknown; mapping it established the human locus and a foundation for disease-gene linkage.\",\n      \"evidence\": \"FISH mapping with cDNA and genomic probes on lymphocyte chromosome spreads\",\n      \"pmids\": [\"2071143\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address the protein's biochemical function\", \"No mutation or phenotype data\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"It was unclear whether the gene was subject to genomic imprinting; allelic expression analysis showed biallelic expression, ruling out imprinting as a regulatory layer.\",\n      \"evidence\": \"Linkage analysis and RT-PCR of allelic expression in mouse crosses with maternal/paternal chromosome imbalances\",\n      \"pmids\": [\"7959780\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mouse data; human imprinting status not directly tested in this finding\", \"No mechanistic link to enzyme protection\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The disease mechanism of galactosialidosis was resolved by establishing that CTSA loss causes secondary deficiency of both GLB1 and NEU1, defining PPCA as a protector of these enzymes' stability.\",\n      \"evidence\": \"CTSA mutation analysis in galactosialidosis patients with computational prediction and review of biochemical consequences\",\n      \"pmids\": [\"23915561\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of how PPCA physically protects GLB1/NEU1 not detailed here\", \"Does not address other PPCA substrates or roles\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The requirement of PPCA for partner enzyme activity was confirmed directly in patient cells rather than inferred, by measuring impaired β-galactosidase and neuraminidase activity in fibroblasts carrying CTSA mutations.\",\n      \"evidence\": \"Enzymatic assays in cultured patient skin fibroblasts with Sanger-confirmed CTSA mutations\",\n      \"pmids\": [\"31044084\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single patient/single lab\", \"Does not resolve which residues mediate enzyme protection\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"A protective function did not explain whether PPCA itself acts proteolytically; CTSA was shown to degrade LAMP2a in lysosomes, linking it to regulation of chaperone-mediated autophagy.\",\n      \"evidence\": \"Western blot, RT-PCR, immunocytochemistry and lysosomal fractionation in leptin-treated canine mammary adenocarcinoma cells\",\n      \"pmids\": [\"33255835\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Demonstrated in a canine cancer cell line\", \"Direct proteolysis of LAMP2a by PPCA not reconstituted biochemically\", \"Generality across human tissues unestablished\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"How specific missense mutations abolish PPCA function was addressed by showing a p.Gln436Arg variant impairs dimerization, establishing homodimerization as a requirement for maturation and activity.\",\n      \"evidence\": \"In vitro functional analysis and enzymatic assay of an exome-identified CTSA variant\",\n      \"pmids\": [\"40165614\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single variant, single study\", \"Structural basis of dimerization defect not resolved\", \"Link between dimerization and enzyme-protection function not directly tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular interface by which PPCA physically associates with and protects GLB1 and NEU1, and the structural relationship between its protective and proteolytic functions, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the PPCA-GLB1-NEU1 complex in the corpus\", \"Direct substrate repertoire of PPCA protease activity incompletely defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GLB1\", \"NEU1\", \"LAMP2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":5,"faith_pct":80.0}}